Targeting Src SH3 domain-mediated glycolysis of HSC suppresses transcriptome, myofibroblastic activation, and colorectal liver metastasis.
Yuanguo WangXianghu WangBing BaiAurpita ShahaXipu HeYingzi HeZhenqing YeVijay H ShahNingling KangPublished in: Hepatology (Baltimore, Md.) (2024)
The Src SH3 domain-facilitated metabolic reprogramming induced by TGFβ1 represents a target to inhibit CAF activation and the pro-metastatic liver microenvironment.